AI assistant
HEALTHEQUITY, INC. — Director's Dealing 2016
Oct 27, 2016
30722_dirs_2016-10-27_71218625-cc61-410c-8ba1-6fe3e226e2d7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: HEALTHEQUITY INC (HQY)
CIK: 0001428336
Period of Report: 2016-10-25
Reporting Person: Rana Manu S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-10-25 | Common Stock | S | 294116 | $35.85 | Disposed | 382352 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $21.27 | 2026-02-01 | Common Stock (15000) | 15000 | Direct |
| Restricted Stock Unit | $ | Common Stock (795) | 795 | Direct | |
| Stock Option (right to buy) | $1.25 | 2021-10-25 | Common Stock (7500) | 7500 | Direct |
| Stock Option (right to buy) | $1.25 | 2022-04-26 | Common Stock (15000) | 15000 | Direct |
| Stock Option (right to buy) | $1.5 | 2023-05-09 | Common Stock (15000) | 15000 | Direct |
| Stock Option (right to buy) | $14 | 2024-07-30 | Common Stock (15000) | 15000 | Direct |
| Stock Option (right to buy) | $25.39 | 2025-03-26 | Common Stock (15000) | 15000 | Direct |
Footnotes
F1: The number of shares sold was mistakenly reported as 330,882, and the amount of securities beneficially owned following the reported transaction was correspondingly incorrect. The correct number of shares sold, and the correct amount of securities beneficially owned following the reported transaction, are reported here.
F2: Price of $35.85 does not reflect underwriter discount or fees.
F3: All securities are held of record by Financial Partners Fund I, L.P. ("FPF I"), a Delaware limited partnership. The reporting person is a managing principal of FPF I. The reporting person disclaims beneficial ownership of the securities held by FPF I except to the extent of his pecuniary interest therein.
F4: The option became exercisable as to 7,500 shares upon the reporting person's reelection to the issuer's board of directors at the issuer's 2016 Annual Meeting of Stockholders held on June 23, 2016. The remaining 7,500 shares will become exercisable on January 31, 2017; provided, that the reporting person continues to serve as a director of the issuer through such date.
F5: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F6: The restricted stock units vested as to 397 shares on August 1, 2016 and will vest as to the remaining 398 shares on November 1, 2016. Vested shares will be delivered to the reporting person upon the earlier of a change of control of the issuer (as defined in the issuer's 2014 equity incentive plan), or the reporting person's termination of service (as defined in the issuer's 2014 equity incentive plan), or the reporting person's death.
F7: The option is immediately exercisable.